Because patients diagnosed with nonischemic cardiomyopathy and eligible for genetic analysis in our hospital require detailed cardiovascular examinations due to disease progression, the DSG2 p.Arg119Ter variant might be more common in patients with advanced heart failure than in the general population. This evidence concerns the gene DSG2 and heart failure.